| Literature DB >> 32006899 |
Xiaoxia Liu1, Yiyang Li1, Jihong Wen1, Tingting Qi1, Yanli Wang2.
Abstract
This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editor-in-Chief and the corresponding author. The panels from Figure 2C appear similar to panels from Figure 2C (after 180-deg flip) of the article previously published by Chunling Xu, Chunmei Hu, Yingxue Wang and Shu Liu in Biomedicine & Pharmacotherapy 117 (2019) 109153 https://doi.org/10.1016/j.biopha.2019.109153 and Figure 8B of the article previously published by Dongmei Han, Jianfeng Wang and Guanghui Cheng in Oncotarget 9 (2018) 2395-2409 https://doi.org/10.18632/oncotarget.23416. The panels from figure 2G appear similar to panels from Figure 6D (after 180-deg flip) of the article previously published by Zhiguang Yang, Xingyu Lin, Peng Zhang, Yunpeng Liu, Zihao Liu, Benxin Qian, Xing Liu and Guoguang Shao in Biomedicine & Pharmacotherapy 124 (2020) 109858 https://doi.org/10.1016/j.biopha.2020.109858 and Figure 5c of the article previously published by Zhen Liang, Xiao Wang, Xin Xu, Bo Xie, Alin Ji, Shuai Meng, Shiqi Li, Yi Zhu, Jian Wu, Zhenghui Hu, Yiwei Lin, Xiangyi Zheng, Liping Xie and Ben Liu in Molecular Cancer 16 (2017) 96 https://doi.org/10.1186/s12943-017-0664-1.Entities:
Keywords: Ovarian cancer; ROCK2; TTN-AS1; miR-139-5p
Mesh:
Substances:
Year: 2020 PMID: 32006899 DOI: 10.1016/j.biopha.2020.109882
Source DB: PubMed Journal: Biomed Pharmacother ISSN: 0753-3322 Impact factor: 7.419